OTCPK:DIZT.F

Stock Analysis Report

Executive Summary

Dignitana AB (publ.), a medical technology company, manufactures and sells medical cooling devices in the United States and internationally.

Snowflake

Fundamentals

Mediocre balance sheet with weak fundamentals.

Risks

  • Dignitana AB (publ.) is not covered by any analysts.

Share Price & News

How has Dignitana AB (publ.)'s share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

DIZT.F

0.7%

US Medical Equipment

-0.2%

US Market


1 Year Return

73.5%

DIZT.F

9.5%

US Medical Equipment

1.1%

US Market

DIZT.F outperformed the Medical Equipment industry which returned 9.9% over the past year.

DIZT.F outperformed the Market in United States of America which returned 1.6% over the past year.


Share holder returns

DIZT.FIndustryMarket
7 Day0%0.7%-0.2%
30 Day13.3%0.1%2.5%
90 Day6.2%2.5%1.6%
1 Year73.5%73.5%10.4%9.5%3.4%1.1%
3 Year-59.0%-59.0%69.3%64.1%45.2%35.8%
5 Yearn/a138.0%110.9%62.6%44.8%

Price Volatility Vs. Market

How volatile is Dignitana AB (publ.)'s share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Dignitana AB (publ.) undervalued based on future cash flows and its price relative to the stock market?

9.02x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Dignitana AB (publ.) to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Dignitana AB (publ.) to establish if it is available at substantial discount.


Price Based on Earnings

Dignitana AB (publ.) is loss making, we can't compare its value to the US Medical Equipment industry average.

Dignitana AB (publ.) is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Dignitana AB (publ.), we can't assess if its growth is good value.


Price Based on Value of Assets

Dignitana AB (publ.) is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Dignitana AB (publ.) expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dignitana AB (publ.) has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of DIZT.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Dignitana AB (publ.)'s filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Dignitana AB (publ.) performed over the past 5 years?

-10.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Dignitana AB (publ.) does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Dignitana AB (publ.)'s 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Dignitana AB (publ.)'s 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Dignitana AB (publ.) has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Dignitana AB (publ.) has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Dignitana AB (publ.) improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Dignitana AB (publ.)'s financial position?


Financial Position Analysis

Dignitana AB (publ.) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Dignitana AB (publ.)'s cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Dignitana AB (publ.)'s level of debt (15.1%) compared to net worth is satisfactory (less than 40%).

Unable to establish if Dignitana AB (publ.)'s debt level has increased without past 5-year debt data.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 3.7x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Dignitana AB (publ.) has less than a year of cash runway based on current free cash flow.

Dignitana AB (publ.) has less than a year of cash runway if free cash flow continues to reduce at historical rates of -31% each year.


Next Steps

Dividend

What is Dignitana AB (publ.)'s current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Dignitana AB (publ.)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Dignitana AB (publ.)'s dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Dignitana AB (publ.) has not reported any payouts.

Unable to verify if Dignitana AB (publ.)'s dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Dignitana AB (publ.) has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Dignitana AB (publ.)'s salary, the management and board of directors tenure and is there insider trading?

0.7yrs

Average management tenure


CEO

Bill Cronin (54yo)

0yrs

Tenure

kr1,711,000

Compensation

Mr. William Cronin, also known as Bill, has been the Chief Executive Officer of Dignitana Inc. since November 8, 2016. Mr. Cronin serves as the Chief Executive Officer and Director of Dignitana AB. 


CEO Compensation Analysis

Bill's remuneration is lower than average for companies of similar size in United States of America.

Insufficient data for Bill to compare compensation growth.


Management Age and Tenure

0.7yrs

Average Tenure

54yo

Average Age

The average tenure for the Dignitana AB (publ.) management team is less than 2 years, this suggests a new team.


Board Age and Tenure

1.5yrs

Average Tenure

55yo

Average Age

The average tenure for the Dignitana AB (publ.) board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

Buykr4,80010 Sep 19
Adma Forvaltnings AB
EntityCompany
Shares5,900
Max Pricekr0.81
Buykr66,01006 Sep 19
Adma Forvaltnings AB
EntityCompany
Shares80,000
Max Pricekr0.83
Buykr437,71404 Sep 19
Adma Forvaltnings AB
EntityCompany
Shares540,000
Max Pricekr0.83
Buykr247,96301 Jul 19
Adma Forvaltnings AB
EntityCompany
Shares280,000
Max Pricekr0.92
Buykr50,81020 Jun 19
Adma Forvaltnings AB
EntityCompany
Shares63,055
Max Pricekr0.82
Buykr26,59617 Jun 19
Adma Forvaltnings AB
EntityCompany
Shares38,472
Max Pricekr0.73
Buykr129,38612 Jun 19
Adma Forvaltnings AB
EntityCompany
Shares207,156
Max Pricekr0.64
Buykr41,67210 Jun 19
Adma Forvaltnings AB
EntityCompany
Shares70,000
Max Pricekr0.60
Buykr34,19404 Jun 19
Adma Forvaltnings AB
EntityCompany
Shares57,879
Max Pricekr0.61
Buykr162,46329 May 19
Adma Forvaltnings AB
EntityCompany
Shares283,438
Max Pricekr0.59
Buykr71,10617 May 19
Adma Forvaltnings AB
EntityCompany
Shares119,836
Max Pricekr0.63

Ownership Breakdown


Management Team

  • Jim McKinney (66yo)

    President & COO

    • Tenure: 1.5yrs
  • Jane Wall

    Director of Clinical Services

    • Tenure: 0yrs
  • Mary Hatcher

    Chief Financial Officer

    • Tenure: 0.7yrs
  • Mikael Wahlgren (54yo)

    Deputy MD & Director

    • Tenure: 1.5yrs
    • Compensation: kr973.00k
  • Bill Cronin (54yo)

    CEO & Director

    • Tenure: 0yrs
    • Compensation: kr1.71m
  • Melissa Bourestom (52yo)

    VP of Marketing & Investor Relations

    • Tenure: 0yrs
  • Anette Cronstroem

    Executive Officer

    • Tenure: 0yrs
    • Compensation: kr107.00k
  • Thomas Joyce

    Executive Officer

    • Tenure: 0yrs
    • Compensation: kr107.00k
  • Cameron O’Mara

    Vice President Global Sales

    • Tenure: 0.7yrs

Board Members

  • Pontus Kristiansson (48yo)

    Director

    • Tenure: 0.7yrs
  • Thomas Kelly (56yo)

    Chairman of the Board

    • Tenure: 1.5yrs
    • Compensation: kr107.00k
  • Ingrid Heiman (61yo)

    Director

    • Tenure: 1.5yrs
    • Compensation: kr201.00k
  • Mikael Wahlgren (54yo)

    Deputy MD & Director

    • Tenure: 1.5yrs
    • Compensation: kr973.00k
  • Bill Cronin (54yo)

    CEO & Director

    • Tenure: 0yrs
    • Compensation: kr1.71m
  • Greg Dingizian (59yo)

    Director

    • Tenure: 0.7yrs

Company Information

Dignitana AB (publ.)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Dignitana AB (publ.)
  • Ticker: DIZT.F
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr379.073m
  • Listing Market Cap: kr39.074m
  • Shares outstanding: 48.60m
  • Website: https://dignitana.com

Number of Employees


Location

  • Dignitana AB (publ.)
  • Traktorgränden 3
  • Lund
  • Skåne County
  • 226 60
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DIGNOM (OMX Nordic Exchange Stockholm)YesShare CapitalSESEKJun 2009
DIZT.FOTCPK (Pink Sheets LLC)YesShare CapitalUSUSDJun 2009

Biography

Dignitana AB (publ.), a medical technology company, manufactures and sells medical cooling devices in the United States and internationally. Its principal product is DigniCap, a scalp cooling system used d ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 01:19
End of Day Share Price2019/09/10 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.